Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Prevention and Management of Infusion-Associated Reactions in the Comparison of Alemtuzumab and Rebif(®) Efficacy in Multiple Sclerosis (CARE-MS) Program.

Caon C, Namey M, Meyer C, Mayer L, Oyuela P, Margolin DH, Rizzo M.

Int J MS Care. 2015 Jul-Aug;17(4):191-8. doi: 10.7224/1537-2073.2014-030.

2.

Nurses' perspective on approaches to limit flu-like symptoms during interferon therapy for multiple sclerosis.

Filipi ML, Beavin J, Brillante RT, Costello K, Hartley GC, Hartley K, Namey M, O'Leary S, Remington G.

Int J MS Care. 2014 Spring;16(1):55-60. doi: 10.7224/1537-2073.2013-006.

3.

Monitoring my multiple sclerosis: a patient-administered health-assessment scale.

Gulick EE, Namey M, Halper J.

Int J MS Care. 2011 Fall;13(3):137-45. doi: 10.7224/1537-2073-13.3.137.

4.

Best practices in multiple sclerosis: infusion reactions versus hypersensitivity associated with biologic therapies.

Namey M, Halper J, O'leary S, Beavin J, Bishop C.

J Infus Nurs. 2010 Mar-Apr;33(2):98-111. doi: 10.1097/NAN.0b013e3181cfd36d. Review.

PMID:
20228647
5.

Long-term treatment optimization in individuals with multiple sclerosis using disease-modifying therapies: a nursing approach.

Denis L, Namey M, Costello K, Frenette J, Gagnon N, Harris C, Lowden D, McEwan L, Morrison W, Poirier J.

J Neurosci Nurs. 2004 Feb;36(1):10-22.

PMID:
14998102
6.

Rethinking cognitive function in multiple sclerosis: a nursing perspective.

Halper J, Kennedy P, Miller CM, Morgante L, Namey M, Ross AP.

J Neurosci Nurs. 2003 Apr;35(2):70-81. Review.

PMID:
12795033
7.

Adherence to disease-modifying therapy in multiple sclerosis: Part II.

Holland N, Wiesel P, Cavallo P, Edwards C, Halper J, Kalb R, Morgante L, Namey M, O'Leary M, Smith-Williamson L.

Rehabil Nurs. 2001 Nov-Dec;26(6):221-6.

PMID:
12035722
8.

Adherence to disease-modifying therapy in multiple sclerosis: Part I.

Holland N, Wiesel P, Cavallo P, Edwards C, Halper J, Kalb R, Morgante L, Namey M, O'Leary M, Smith-Williamson L.

Rehabil Nurs. 2001 Sep-Oct;26(5):172-6.

PMID:
12035685
9.

A replicated prospective investigation of life stress, coping, and depressive symptoms in multiple sclerosis.

Aikens JE, Fischer JS, Namey M, Rudick RA.

J Behav Med. 1997 Oct;20(5):433-45.

PMID:
9415854
10.

Multiple sclerosis progression in a natural history study: predictive value of cerebrospinal fluid free kappa light chains.

Rudick RA, Medendorp SV, Namey M, Boyle S, Fischer J.

Mult Scler. 1995 Nov;1(3):150-5.

PMID:
9345445
11.

Distance running improves fitness in asthmatic children without pulmonary complications or changes in exercise-induced bronchospasm.

Nickerson BG, Bautista DB, Namey MA, Richards W, Keens TG.

Pediatrics. 1983 Feb;71(2):147-52.

PMID:
6823415

Supplemental Content

Support Center